Article metrics

Download PDFPDF
The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab

 

Online download statistics by month:

Online download statistics by month: June 2013 to August 2020

AbstractFullPdf
Jun 201323667110
Jul 20131111219
Aug 2013333128
Sep 2013211919
Oct 20132503285
Nov 2013521524
Dec 2013311118
Jan 20143055
Feb 20141157
Mar 20142645
Apr 20143024
May 20143647
Jun 201431916
Jul 20142227
Aug 2014988
Sep 20141866
Oct 20142237
Nov 20142149
Dec 20141411
Jan 2015832
Feb 2015512
Mar 20151353
Apr 2015613
May 2015943
Jun 2015155
Jul 20151233
Aug 2015424
Sep 20152743
Oct 20151033
Nov 20151535
Dec 20151900
Jan 20164434
Feb 20161212
Mar 20161032
Apr 20161547
May 201622103
Jun 20161112
Jul 2016522
Aug 20161332
Sep 20161511
Oct 20161232
Nov 2016812
Dec 2016700
Jan 20171011
Feb 20171700
Mar 20171642
Apr 2017911
May 20171303
Jun 20171935
Jul 20171202
Aug 20174306
Sep 20173634
Oct 20173800
Nov 20174022
Dec 20173101
Jan 20183146
Feb 20182721
Mar 20181221
Apr 20181811
May 20182111
Jun 20183411
Jul 20182400
Aug 20181713
Sep 20182300
Oct 2018602
Nov 20181800
Dec 20181310
Jan 20191203
Feb 20191011
Mar 20192111
Apr 20191600
May 20191600
Jun 20193412
Jul 20191521
Aug 20191600
Sep 2019800
Oct 20192111
Nov 20191331
Dec 20191200
Jan 20201511
Feb 20201711
Mar 20201310
Apr 20201200
May 20201200
Jun 20201400
Jul 20201810
Aug 20202600
Total2156346505